Application 072204
- Type
- ANDA
- Sponsor
- WATSON LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOXAPINE SUCCINATE | LOXAPINE SUCCINATE | CAPSULE;ORAL | EQ 5MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0591-0369 | Loxapine | Loxapine | Actavis Pharma, Inc. | ANDA | Current |
| 68151-2875 | Loxapine | Loxapine | Carilion Materials Management | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |
| 70518-0346 | Loxapine | Loxapine | REMEDYREPACK INC. | ANDA | Current |